1. Clark, M., Cobbold, S., Hale, G., & Waldmann, H. Advantages of rat monoclonal antibodies. Immunol. Today 1983; 4, 100–101.
2. Hale, G., & Waldmann, H. Human complement fixing antibodies in transplantation. In: Hybridoma technology in the biosciences and medicine ed Springer TA. Plenum Press 1985; pp 453–471.
3. Hale, G., Cobbold, S.P., Waldmann, H., Easter, G., Matejtschuk, P., & Coombs, R.R.A. Isolation of low-frequency class-switch variants from rat hybrid myelomas. J. Immunol. Meth. 1987; 103, 59–67.
4. Bruggemann, M., Teale, C., Clark, M., Bindon, C.I., & Waldmann, H. A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions.J. Immunol. 1989; 142, 3145–3150.
5. Hale, G., Clark, M., & Waldmann, H. Therapeutic potential of rat monoclonal antibodies: Isotype specificity of antibody-dependant cell-mediated cytotoxicity with human lymphocytes. J. Immunol. 1985; 134, 3056–3061.